These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 24752885)
21. Susceptibility-Weighted MR Imaging Hypointense Rim in Progressive Multifocal Leukoencephalopathy: The End Point of Neuroinflammation and a Potential Outcome Predictor. Thurnher MM; Boban J; Rieger A; Gelpi E AJNR Am J Neuroradiol; 2019 Jun; 40(6):994-1000. PubMed ID: 31122919 [TBL] [Abstract][Full Text] [Related]
22. [A case of progressive multifocal leukoencephalopathy presenting white matter MRI lesions extending over the cerebral cortex and a marked decrease in cerebral blood flow on SPECT, and associated with HTLV-I infection]. Takase K; Ohyagi Y; Furuya H; Nagashima K; Taniwaki T; Kira J Rinsho Shinkeigaku; 2005 Jun; 45(6):426-30. PubMed ID: 16022467 [TBL] [Abstract][Full Text] [Related]
24. Use of diffusion-weighted imaging to evaluate the initial response of progressive multifocal leukoencephalopathy to highly active antiretroviral therapy: early experience. Buckle C; Castillo M AJNR Am J Neuroradiol; 2010 Jun; 31(6):1031-5. PubMed ID: 20360338 [TBL] [Abstract][Full Text] [Related]
26. Immune Reconstitution Inflammatory Syndrome Unmasking or Worsening AIDS-Related Progressive Multifocal Leukoencephalopathy: A Literature Review. Fournier A; Martin-Blondel G; Lechapt-Zalcman E; Dina J; Kazemi A; Verdon R; Mortier E; de La Blanchardière A Front Immunol; 2017; 8():577. PubMed ID: 28588577 [TBL] [Abstract][Full Text] [Related]
27. Magnetization transfer study of HIV encephalitis and progressive multifocal leukoencephalopathy. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine. Dousset V; Armand JP; Lacoste D; Mièze S; Letenneur L; Dartigues JF; Caill JM AJNR Am J Neuroradiol; 1997 May; 18(5):895-901. PubMed ID: 9159367 [TBL] [Abstract][Full Text] [Related]
28. Immune reconstitution is not a prognostic factor in progressive multifocal leukoencephalopathy. Harrison DM; Newsome SD; Skolasky RL; McArthur JC; Nath A J Neuroimmunol; 2011 Sep; 238(1-2):81-6. PubMed ID: 21840066 [TBL] [Abstract][Full Text] [Related]
30. Immune reconstitution associated with progressive multifocal leukoencephalopathy in human immunodeficiency virus: a case discussion and review of the literature. Travis J; Varma A; duPlessis D; Turnbull I; Vilar FJ Neurologist; 2008 Sep; 14(5):321-6. PubMed ID: 18784604 [TBL] [Abstract][Full Text] [Related]
31. Progressive multifocal leukoencephalopathy: value of diffusion-weighted and contrast-enhanced magnetic resonance imaging for diagnosis and treatment control. Küker W; Mader I; Nägele T; Uhl M; Adolph C; Klose U; Herrlinger U Eur J Neurol; 2006 Aug; 13(8):819-26. PubMed ID: 16879291 [TBL] [Abstract][Full Text] [Related]
32. Hyperperfusion in progressive multifocal leukoencephalopathy is associated with disease progression and absence of immune reconstitution inflammatory syndrome. Khoury MN; Gheuens S; Ngo L; Wang X; Alsop DC; Koralnik IJ Brain; 2013 Nov; 136(Pt 11):3441-50. PubMed ID: 24088807 [TBL] [Abstract][Full Text] [Related]
33. Magnetic resonance imaging changes following natalizumab discontinuation in multiple sclerosis patients with progressive multifocal leukoencephalopathy. Hodel J; Bapst B; Outteryck O; Verclytte S; Deramecourt V; Benadjaoud MA; Pruvo JP; Vermersch P; Leclerc X Mult Scler; 2018 Dec; 24(14):1902-1908. PubMed ID: 29343163 [TBL] [Abstract][Full Text] [Related]
34. Diagnostic criteria and clinical procedures in HIV-1 associated progressive multifocal leukoencephalopathy. von Giesen HJ; Neuen-Jacob E; Dörries K; Jablonowski H; Roick H; Arendt G J Neurol Sci; 1997 Mar; 147(1):63-72. PubMed ID: 9094062 [TBL] [Abstract][Full Text] [Related]
35. Progressive multifocal leukoencephalopathy and other forms of JC virus disease. Brew BJ; Davies NW; Cinque P; Clifford DB; Nath A Nat Rev Neurol; 2010 Dec; 6(12):667-79. PubMed ID: 21131916 [TBL] [Abstract][Full Text] [Related]
36. Punctate pattern: A promising imaging marker for the diagnosis of natalizumab-associated PML. Hodel J; Darchis C; Outteryck O; Verclytte S; Deramecourt V; Lacour A; Zins M; Pruvo JP; Vermersch P; Leclerc X Neurology; 2016 Apr; 86(16):1516-23. PubMed ID: 27009257 [TBL] [Abstract][Full Text] [Related]
37. Immune-reconstitution Inflammatory Syndrome in Multiple Sclerosis Patients Treated With Natalizumab: A Series of 4 Cases. N'gbo N'gbo Ikazabo R; Mostosi C; Quivron B; Delberghe X; El Hafsi K; Lysandropoulos AP Clin Ther; 2016 Mar; 38(3):670-5. PubMed ID: 26856928 [TBL] [Abstract][Full Text] [Related]
38. Metabolic profiles by 1H-magnetic resonance spectroscopy in natalizumab-associated post-PML lesions of multiple sclerosis patients who survived progressive multifocal leukoencephalopathy (PML). Schneider R; Bellenberg B; Hoepner R; Kolb EM; Ellrichmann G; Haghikia A; Gold R; Lukas C PLoS One; 2017; 12(4):e0176415. PubMed ID: 28445498 [TBL] [Abstract][Full Text] [Related]
39. Progressive multifocal leukoencephalopathy and human immunodeficiency virus-associated white matter lesions in AIDS: magnetization transfer MR imaging. Ernst T; Chang L; Witt M; Walot I; Aronow H; Leonido-Yee M; Singer E Radiology; 1999 Feb; 210(2):539-43. PubMed ID: 10207441 [TBL] [Abstract][Full Text] [Related]
40. Progressive Multifocal Leukoencephalopathy Diagnosed by Brain Biopsy, not by the DNA Test for JC Virus. Lee SY; Ko HC; Kim SI; Lee YS; Son BC Asian J Neurosurg; 2019; 14(1):240-244. PubMed ID: 30937044 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]